Question Bank › Growing out of the old self

Growing out of the old self

Growing out of the old self: management itself says the company has quietly become a different business, and the numbers

Calls Tested
492
Answered YES
4
Hit Rate
0.8%
rare by design

Ascendis Pharma A/S (ASND) — this company's answers

NO on the Q1 2018 call 2018-05-30 C+
The model's full reasoning — Q1 2018 call → NOWe need answer only YES or NO. Need evaluate if management conveys company today running on different basis than reported results/reputation built on, with both halves: change already real, and record/perception lag. Need use only transcript. Transcript: Ascendis Pharma Q1 2018 earnings call. Management discusses pipeline progress: TransCon Growth Hormone Phase 3 ongoing, TransCon PTH Phase 1 completed and moving to Phase 3, TransCon CNP Phase 1 started. They talk about platform, rare disease endocrinology pipeline. Jan Mikkelsen: "We have now three product candidates in clinical development, all of which will have significant clinical milestones in next 12 months." He reflects on TransCon PTH potential. He says "Our development process start by identifying unmet medical need..." etc. He says "We are executing on all fronts according to our goals and timelines. The Phase 1 trial is now completed. The preclinical safety program to support Phase 3 indication is being finalized and Phase 3 manufacturing at commercial scale is in place. We have also developed a simple and easy to use pen device..." He mentions Tom Larson joined as Chief Commercial Officer. Jonathan Leff reviews clinical progress. Scott Smith financial update: net loss increased, R&D costs higher due to Phase 3 programs, manufacturing validation batches, etc. No mention of company changing basis. It's a biotech with pipeline progressing. No indication that reported results or reputation lag a change. They are still same business: developing rare disease endocrinology products using TransCon platform. No "different basis" like from research to commercial, or from platform to product? They have three candidates in clinical development, but that's progress. No management statement that company now operates differently than before. They mention "we have built a diversified rare disease endocrinology pipeline" and "intent to further expand" but that's not a change of basis. No contrast between reported numbers and new reality. So answer NO. Need output only YES or NO.

← Back to the full ASND analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that THE COMPANY TODAY IS RUNNING ON A DIFFERENT BASIS THAN THE COMPANY ITS REPORTED RESULTS AND REPUTATION WERE BUILT ON \u2014 that is, does management itself describe the company as having crossed, recently and substantially, into being a different kind of business than it was, while making clear that this change is not yet what the reported numbers or the outside picture of the company reflect? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent posture with BOTH halves present as a present-tense reality: (1) A CHANGE OF BASIS, ALREADY REAL. Management describes the company as now operating on a foundation that is genuinely different from what it used to run on \u2014 in whatever form fits the industry: what it sells, who pays it, how it earns, what it owns, what it can do, or what drives its results has changed at the root, and management treats this as an accomplished condition of the company today, grounded in things already happening or already in place (real current activity, completed work, business already being won or delivered), not as a plan, a launch announcement, or a vision. The change may have built over several periods or arrived recently; what matters is that management speaks about the new basis as how the company actually works NOW, not as where it is headed. (2) MANAGEMENT SAYS THE RECORD AND THE PERCEPTION LAG THE CHANGE. Management conveys \u2014 directly or plainly in substance \u2014 that the results being reported, or the way outsiders still see and measure the company, belong to the OLD basis: the new basis contributes only early or partially to the numbers just presented; the metrics, mix, or storyline people associate with the company describe what it was; or management indicates that what the company has already become will only become visible in results from here. The essence is a management team telling investors, in its own voice: the company you are grading is not quite the company we are now running. Answer NO if the call is ordinary reporting of a company continuing in its established form, however strong or confident. NO if the change described is a routine product refresh, a normal line extension, ordinary mix improvement, or incremental progress within the same basis. NO if the new basis is only planned, being tested, launching soon, or described as a future direction rather than as already how the company operates. NO if management describes the change but conveys no sense that the reported results or outside perception lag it \u2014 for example if the new basis is already fully reflected in the numbers and fully understood. NO if the only contrast is between a bad quarter and a good quarter, or between this year and last year, within an unchanged business. NO if the framing is generic transformation, journey, or evolution boilerplate without a concrete description of what is different about how the company now works. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
SANG Sangoma Technologies Corporation Q2 2024 2024-02-08 D
WD Walker & Dunlop, Inc. Q2 2022 2022-08-09 C+
KD Kyndryl Holdings, Inc. Q4 2021 2022-03-01 C+
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+

How the model reasoned

CALX · Q1 2023 → YESThe question is whether management conveys that the company today is running on a different basis than what its reported results and reputation were built on. Both parts: a change of basis already rea...YES The transcript shows management describing the company as now operating on a fundamentally different basis—selling into a new market of broadband service providers building consolidated networks, shifting from a legacy cyclical model to sequential revenue through platforms, clouds, and managed services—while treating this as an accomplished reality today, not a future plan. They emphasize numbers like 988 BSP deployments, 865 cloud customers, and 334 managed services customers, along with three years of over 25% growth, as evidence of this new foundation already in place.
SANG · Q2 2024 → YESThe question is whether management conveys that the company today is running on a different basis than the one its reported results and reputation were built on. Both parts: a real change of basis alr...
WD · Q2 2022 → YESThe question is whether management conveys that the company today is running on a different basis than the company its reported results and reputation were built on. Specifically, two parts: a change ...

More from the question bank

Their own money on the lineQuestions aim low, answers land highMid-period crossingsFree option on their own operationsThe company is outgrowing its own explanatioUndersized for what it has already been handAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.